Hologic Rings Nasdaq Opening Bell to Kick-Off Breast Cancer Awareness Month
In full transparency, the following press release was submitted to SOURCE media from its business wire service. *** MARLBOROUGH –
Read more
Hologic Inc.
Hologic & Mary J. Blige Launch ‘Good Morning Gorgeous’ Sweepstakes To Increase Awareness of Preventive Care
In full transparency, the following press release was submitted to SOURCE media through its business wire service. (Hologic photo) ***
Read more
U.S. Court of Appeals Affirms 2018 Ruling Barring Minerva from Challenging Marlborough Company’s Patent Rights
In full transparency, the following is a press release submitted to SOURCE media via its business wire service (stock photo).
Read more
Marlborough-Based Hologic’s COVID-19 Tests Detect Omicron Variant
In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH –
Read more
Marlborough-Based Hologic Acquires Bolder Surgical
In full transparency, the following press release was submitted to SOURCE media via a business wire service. *** MARLBOROUGH –
Read more
Marlborough-Based Hologic’s Acquisition of Mobidiag Worth $808 Million
In full transparency, the following is a press release that was sent to SOURCE media through its business wire service.
Read more
American College of Obstetricians and Gynecologists Supports Marlborough Company’s Procedure For Uterine Fibroids
In full transparency, the following was submitted to SOURCE media through its business wire service. *** MARLBOROUG – Hologic announced
Read more
Marlborough-Based Hologic Acquires Biotheranostics for $230 Million
The following is a press release submitted to SOURCE through its business wire service. *** MARLBOROUGH – Hologic, Inc. has
Read more
Marlborough Company Awarded $119 Million Government Contract To Scale Up To 13 Million COVID Tests Per Month
*** The following is a press release submitted to SOURCE media through its business wire service. *** MARLBOROUGH – Marlborough-based
Read more
FDA Amends Emergency Use Authorization for Hologic’s Aptima SARS-CoV-2 Assay to Include COVID-19 Testing of Asymptomatic Individuals
MARLBOROUGH – Hologic, Inc. announced today, October 6, its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from
Read more